con·va·les·cent /ˌkänvəˈles(ə)nt/
adjective : (of a person) recovering from an illness or operation. noun : a person who is recovering after an illness or operation.
Berbagai metode terapi telah di kembangkan untuk mengobati pasien Covid-19 salah satunya adalah terapi plasma konvalesent. Teknik terapinya dengan mengambil plasma dari pendonor yang telah sembuh dari covid-19 kemudian plasma tersebut di berikan kepada pasien yang masih menjalani perawatan.
Di Amerika Serikat terapi konvalesent telah mendapatkan persetujuan Food and Drug Administration (FDA). Serta di gunakan secara luas dengan sebuah program Expanded Access Program (EAP) kerjasama antara FDA dan Mayo clinic guna mengembangkan penelitian pada terapi konvalesent. Vaksin covid-19 yang belum selesai diroduksi dan masih menjalani uji klinis, membuat terapi plasma menjadi alternatif yang menjanjikan. Pasien covid-19 memerlukan waktu 1-3 minggu untuk membentuk sistem antibodinya sendiri, dengan terapi plasma maka waktu dibutuhkan akan menjadi lebih pendek. Mencegah pasien jatuh kepada keadaan kritis dan gangguan pernafasan akut yang mungkin dapat terjadi.
Darah dari pendonor yang telah sembuh covid-19 akan di saring sehingga menyisakan plasma dan antibodi saja. Plasma tersebut kemudian diberikan kepada pasien agar meningkatkan kemampuan tubuh melawan virus corona. Sama seperti transfusi darah, pemberian plasma harus pula memperhatikan prosedur keamanan pasien. Para ahli berpendapat bahwa terapi plasma sangat aman dengan resiko yang minimal. Walaupun ada resiko seperti alergi, sesak nafas, infeksi penyakit HIV, Hepatitis B dan C. Dengan prosedur keamanan yang baik resiko- resiko tersebut akan sangat minimal atau tidak ada sama sekali.
Terapi Plasma Konvalesent telah ada sejak 100 tahun yang lalu, digunakan dalam pengobatan ebola, polio, Mers, dan SARS. Berdasarkan pengalaman, terapi Plasma aman digunakan, dan mampu membersihkan virus lebih cepat terutama saat terapi plasma diberikan pada awal perawatan(Hematology.org).
Donor dilakukan setelah 3 bulan pasca pendonor dinyatakan sembuh dari Covid-19. Teknik pendonorannya adalah dengan cara apharesis, yaitu menyaring komponen darah yang dibutuhkan (misalnya plasma) dan mengembalikan komponen lain kedalam tubuh si pendonor. Karena plasma yang diambil maka pemulihan dari si pendonor akan berlangsung dengan cepat, sehingga pendonor dapat melakukan donor plasma setiap minggu sebelum titer antibodinya menurun.
konvalesent memiliki keunggulan pada tingkat konversi hasil PCR pasien dari positif ke negatif dalam 72jam. Meskipun pada pasien sakit parah, terapi konservalesent tidak begitu terlihat manfaatnya secara signifikan. Namun saat terapi ini diberikan kepada pasien yang baru saja terinfeksi covid-19 , dapat mengurangi resiko terjadinya gangguan pernafasan akut(Libster et al., 2021).
Pasien dgn terapi konvalesent pasien tidak mendapat terapi konvalesent konversi swab positif ke negatif 87,2% 37,5% perbaikan klinis dalam 28 hari 51,9% 43,1%
“Hanya diberikan kepada pasien dengan gejala berat untuk membantu mempercepat penyembuhan, bukan untuk pencegahan. Namun terapi plasma penyembuhan ini menjadi pengobatan alternatif hingga ditemukan vaksinnya”(dr. Sumardi, Sp.PD, KP., FINASIM)
Persyaratan donor plasma konvalesent
Sukarela untuk donor plasma Bersedia tanda tangan inform consent Riwayat konfirmasi positif covid-19 dengan PCR Swab Telah sembuh dari covid-19 dengan PCR hasil negatif dua kali berturut-turut 5. BB minimal 55kg Suhu tubuh 36,5 – 37,5c Memenuhi syarat donor darah secara umum: tifak hipertensi, Tidak DM, tidak ada penyakit jantung, tidak hepatitis B/C, tidak sefilis, tidak HIV/AIDS.
Tempat donor plasma konvalesent di Jakarta
PMI Jakarta Unit transfusi darah (UTD) RSPAD Gatot Soebroto
Donor Plasma Convalesent Pasca Vaksin
Setelah dilakukan vaksinasi covid 19, seseorang masih dapat melakukan donor plasma dengan ketentuan:
Bila tidak ada KIPI atau keluhan pasca vaksin dapat melakukan donor setelah 3 hari pasca vaksin, sedangkan bila terdapat keluhan sedang-berat pasca vaksin maka donor plasma dapat dilakukan setelah 4 minggu setelah vaksin kedua. Pada vaksin pertama dapat melakukan donor 3 hari setelah vaksin. Pada vaksin kedua dapat melakukan donor 7 hari setelah vaksin.
Referensi:
6609083
{6609083:TXTZ5S2B},{6609083:PEKWT8G8},{6609083:IJGRJQA9},{6609083:IC456B48},{6609083:Z8QIKE6Y}
1
apa
50
default
3189
https://deiari.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Z8QIKE6Y%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Libster%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLibster%2C%20R.%2C%20P%26%23xE9%3Brez%20Marc%2C%20G.%2C%20Wappner%2C%20D.%2C%20Coviello%2C%20S.%2C%20Bianchi%2C%20A.%2C%20Braem%2C%20V.%2C%20Esteban%2C%20I.%2C%20Caballero%2C%20M.%20T.%2C%20Wood%2C%20C.%2C%20Berrueta%2C%20M.%2C%20Rondan%2C%20A.%2C%20Lescano%2C%20G.%2C%20Cruz%2C%20P.%2C%20Ritou%2C%20Y.%2C%20Fern%26%23xE1%3Bndez%20Vi%26%23xF1%3Ba%2C%20V.%2C%20%26%23xC1%3Blvarez%20Paggi%2C%20D.%2C%20Esperante%2C%20S.%2C%20Ferreti%2C%20A.%2C%20Ofman%2C%20G.%2C%20%26%23x2026%3B%20Polack%2C%20F.%20P.%20%282021%29.%20Early%20High-Titer%20Plasma%20Therapy%20to%20Prevent%20Severe%20Covid-19%20in%20Older%20Adults.%20%26lt%3Bi%26gt%3BNew%20England%20Journal%20of%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%20NEJMoa2033700.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa2033700%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa2033700%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Early%20High-Titer%20Plasma%20Therapy%20to%20Prevent%20Severe%20Covid-19%20in%20Older%20Adults%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romina%22%2C%22lastName%22%3A%22Libster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gonzalo%22%2C%22lastName%22%3A%22P%5Cu00e9rez%20Marc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diego%22%2C%22lastName%22%3A%22Wappner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silvina%22%2C%22lastName%22%3A%22Coviello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Bianchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginia%22%2C%22lastName%22%3A%22Braem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ignacio%22%2C%22lastName%22%3A%22Esteban%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mauricio%20T.%22%2C%22lastName%22%3A%22Caballero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristian%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mabel%22%2C%22lastName%22%3A%22Berrueta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22An%5Cu00edbal%22%2C%22lastName%22%3A%22Rondan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Lescano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pablo%22%2C%22lastName%22%3A%22Cruz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%22%2C%22lastName%22%3A%22Ritou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Fern%5Cu00e1ndez%20Vi%5Cu00f1a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dami%5Cu00e1n%22%2C%22lastName%22%3A%22%5Cu00c1lvarez%20Paggi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebasti%5Cu00e1n%22%2C%22lastName%22%3A%22Esperante%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adri%5Cu00e1n%22%2C%22lastName%22%3A%22Ferreti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gast%5Cu00f3n%22%2C%22lastName%22%3A%22Ofman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00c1lvaro%22%2C%22lastName%22%3A%22Ciganda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roc%5Cu00edo%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Lantos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ricardo%22%2C%22lastName%22%3A%22Valentini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicol%5Cu00e1s%22%2C%22lastName%22%3A%22Itcovici%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Hintze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Laura%22%2C%22lastName%22%3A%22Oyarvide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Candela%22%2C%22lastName%22%3A%22Etchegaray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Neira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivonne%22%2C%22lastName%22%3A%22Name%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julieta%22%2C%22lastName%22%3A%22Alfonso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roc%5Cu00edo%22%2C%22lastName%22%3A%22L%5Cu00f3pez%20Castelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gisela%22%2C%22lastName%22%3A%22Caruso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sof%5Cu00eda%22%2C%22lastName%22%3A%22Rapelius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Alvez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federico%22%2C%22lastName%22%3A%22Etchenique%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federico%22%2C%22lastName%22%3A%22Dimase%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dar%5Cu00edo%22%2C%22lastName%22%3A%22Alvarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sof%5Cu00eda%20S.%22%2C%22lastName%22%3A%22Aranda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22S%5Cu00e1nchez%20Yanotti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juli%5Cu00e1n%22%2C%22lastName%22%3A%22De%20Luca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sof%5Cu00eda%22%2C%22lastName%22%3A%22Jares%20Baglivo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sof%5Cu00eda%22%2C%22lastName%22%3A%22Laudanno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florencia%22%2C%22lastName%22%3A%22Nowogrodzki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramiro%22%2C%22lastName%22%3A%22Larrea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%22%2C%22lastName%22%3A%22Silveyra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Leberzstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alejandra%22%2C%22lastName%22%3A%22Debonis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Molinos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Gonz%5Cu00e1lez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicol%5Cu00e1s%22%2C%22lastName%22%3A%22Kreplak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susana%22%2C%22lastName%22%3A%22Pastor%20Arg%5Cu00fcello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luz%22%2C%22lastName%22%3A%22Gibbons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Althabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Bergel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%20P.%22%2C%22lastName%22%3A%22Polack%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021-01-06%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa2033700%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fdoi%5C%2F10.1056%5C%2FNEJMoa2033700%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220028-4793%2C%201533-4406%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-10T17%3A36%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22IC456B48%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Joyner%20et%20al.%22%2C%22parsedDate%22%3A%222020-09-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJoyner%2C%20M.%20J.%2C%20Bruno%2C%20K.%20A.%2C%20Klassen%2C%20S.%20A.%2C%20Kunze%2C%20K.%20L.%2C%20Johnson%2C%20P.%20W.%2C%20Lesser%2C%20E.%20R.%2C%20Wiggins%2C%20C.%20C.%2C%20Senefeld%2C%20J.%20W.%2C%20Klompas%2C%20A.%20M.%2C%20Hodge%2C%20D.%20O.%2C%20Shepherd%2C%20J.%20R.%20A.%2C%20Rea%2C%20R.%20F.%2C%20Whelan%2C%20E.%20R.%2C%20Clayburn%2C%20A.%20J.%2C%20Spiegel%2C%20M.%20R.%2C%20Baker%2C%20S.%20E.%2C%20Larson%2C%20K.%20F.%2C%20Ripoll%2C%20J.%20G.%2C%20Andersen%2C%20K.%20J.%2C%20%26%23x2026%3B%20Wright%2C%20R.%20S.%20%282020%29.%20Safety%20Update%3A%20COVID-19%20Convalescent%20Plasma%20in%2020%2C000%20Hospitalized%20Patients.%20%26lt%3Bi%26gt%3BMayo%20Clinic%20Proceedings%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B95%26lt%3B%5C%2Fi%26gt%3B%289%29%2C%201888%26%23x2013%3B1897.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mayocp.2020.06.028%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mayocp.2020.06.028%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Safety%20Update%3A%20COVID-19%20Convalescent%20Plasma%20in%2020%2C000%20Hospitalized%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Joyner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katelyn%20A.%22%2C%22lastName%22%3A%22Bruno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20A.%22%2C%22lastName%22%3A%22Klassen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katie%20L.%22%2C%22lastName%22%3A%22Kunze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20W.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20R.%22%2C%22lastName%22%3A%22Lesser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chad%20C.%22%2C%22lastName%22%3A%22Wiggins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathon%20W.%22%2C%22lastName%22%3A%22Senefeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allan%20M.%22%2C%22lastName%22%3A%22Klompas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20O.%22%2C%22lastName%22%3A%22Hodge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20R.%20A.%22%2C%22lastName%22%3A%22Shepherd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20F.%22%2C%22lastName%22%3A%22Rea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20R.%22%2C%22lastName%22%3A%22Whelan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20J.%22%2C%22lastName%22%3A%22Clayburn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20R.%22%2C%22lastName%22%3A%22Spiegel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20E.%22%2C%22lastName%22%3A%22Baker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20F.%22%2C%22lastName%22%3A%22Larson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20G.%22%2C%22lastName%22%3A%22Ripoll%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kylie%20J.%22%2C%22lastName%22%3A%22Andersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20R.%22%2C%22lastName%22%3A%22Buras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20N.%20P.%22%2C%22lastName%22%3A%22Vogt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vitaly%22%2C%22lastName%22%3A%22Herasevich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20J.%22%2C%22lastName%22%3A%22Dennis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riley%20J.%22%2C%22lastName%22%3A%22Regimbal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%20R.%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janis%20E.%22%2C%22lastName%22%3A%22Blair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%20M.%20van%22%2C%22lastName%22%3A%22Buskirk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20L.%22%2C%22lastName%22%3A%22Winters%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Stubbs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noud%20van%22%2C%22lastName%22%3A%22Helmond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20P.%22%2C%22lastName%22%3A%22Butterfield%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20A.%22%2C%22lastName%22%3A%22Sexton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20C.%20Diaz%22%2C%22lastName%22%3A%22Soto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nigel%20S.%22%2C%22lastName%22%3A%22Paneth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20C.%22%2C%22lastName%22%3A%22Verdun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Marks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arturo%22%2C%22lastName%22%3A%22Casadevall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22DeLisa%22%2C%22lastName%22%3A%22Fairweather%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rickey%20E.%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Scott%22%2C%22lastName%22%3A%22Wright%22%7D%5D%2C%22abstractNote%22%3A%22%26lt%3Bh2%26gt%3BAbstract%26lt%3B%5C%2Fh2%26gt%3B%26lt%3Bh3%26gt%3BObjective%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BTo%20provide%20an%20update%20on%20key%20safety%20metrics%20after%20transfusion%20of%20convalescent%20plasma%20in%20hospitalized%20coronavirus%202019%20%28COVID-19%29%20patients%2C%20having%20previously%20demonstrated%20safety%20in%205000%20hospitalized%20patients.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BPatients%20and%20Methods%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BFrom%20April%203%20to%20June%202%2C%202020%2C%20the%20US%20Food%20and%20Drug%20Administration%20Expanded%20Access%20Program%20for%20COVID-19%20convalescent%20plasma%20transfused%20a%20convenience%20sample%20of%2020%2C000%20hospitalized%20patients%20with%20COVID-19%20convalescent%20plasma.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BResults%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BThe%20incidence%20of%20all%20serious%20adverse%20events%20was%20low%3B%20these%20included%20transfusion%20reactions%20%28n%26lt%3Bi%26gt%3B%3D%26lt%3B%5C%2Fi%26gt%3B78%3B%20%26lt%3B1%25%29%2C%20thromboembolic%20or%20thrombotic%20events%20%28n%26lt%3Bi%26gt%3B%3D%26lt%3B%5C%2Fi%26gt%3B113%3B%20%26lt%3B1%25%29%2C%20and%20cardiac%20events%20%28n%3D677%2C%20~3%25%29.%20Notably%2C%20the%20vast%20majority%20of%20the%20thromboembolic%20or%20thrombotic%20events%20%28n%3D75%29%20and%20cardiac%20events%20%28n%3D597%29%20were%20judged%20to%20be%20unrelated%20to%20the%20plasma%20transfusion%20per%20se.%20The%207-day%20mortality%20rate%20was%2013.0%25%20%2812.5%25%2C%2013.4%25%29%2C%20and%20was%20higher%20among%20more%20critically%20ill%20patients%20relative%20to%20less%20ill%20counterparts%2C%20including%20patients%20admitted%20to%20the%20intensive%20care%20unit%20versus%20those%20not%20admitted%20%2815.6%20vs%209.3%25%29%2C%20mechanically%20ventilated%20versus%20not%20ventilated%20%2818.3%25%20vs%209.9%25%29%2C%20and%20with%20septic%20shock%20or%20multiple%20organ%20dysfunction%5C%2Ffailure%20versus%20those%20without%20dysfunction%5C%2Ffailure%20%2821.7%25%20vs%2011.5%25%29.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BConclusion%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BThese%20updated%20data%20provide%20robust%20evidence%20that%20transfusion%20of%20convalescent%20plasma%20is%20safe%20in%20hospitalized%20patients%20with%20COVID-19%2C%20and%20support%20the%20notion%20that%20earlier%20administration%20of%20plasma%20within%20the%20clinical%20course%20of%20COVID-19%20is%20more%20likely%20to%20reduce%20mortality.%26lt%3B%5C%2Fp%26gt%3B%22%2C%22date%22%3A%222020%5C%2F09%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.mayocp.2020.06.028%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mayoclinicproceedings.org%5C%2Farticle%5C%2FS0025-6196%2820%2930651-0%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220025-6196%2C%201942-5546%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-09-04T18%3A06%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22PEKWT8G8%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BWhat%20Is%20Convalescent%20Plasma%20Therapy%20and%20How%20Does%20It%20Fight%20COVID-19%3F%26lt%3B%5C%2Fi%26gt%3B%20%28n.d.%29.%20Discover%20Magazine.%20Retrieved%20September%202%2C%202020%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.discovermagazine.com%5C%2Fhealth%5C%2Fwhat-is-convalescent-plasma-therapy-and-how-does-it-fight-covid-19%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.discovermagazine.com%5C%2Fhealth%5C%2Fwhat-is-convalescent-plasma-therapy-and-how-does-it-fight-covid-19%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22What%20Is%20Convalescent%20Plasma%20Therapy%20and%20How%20Does%20It%20Fight%20COVID-19%3F%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22Convalescent%20plasma%20therapy%2C%20an%20old-school%20weapon%20against%20deadly%20illnesses%2C%20gives%20coronavirus%20patients%20a%20dose%20of%20virus-fighting%20antibodies.%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.discovermagazine.com%5C%2Fhealth%5C%2Fwhat-is-convalescent-plasma-therapy-and-how-does-it-fight-covid-19%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-09-02T03%3A11%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22TXTZ5S2B%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BDiscovering%20Convalescent%20Therapy%20as%20an%20Alternative%20to%20Covid-19%20Treatment%20%7C%20Universitas%20Gadjah%20Mada%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20September%202%2C%202020%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fugm.ac.id%5C%2Fen%5C%2Fnews%5C%2F19650-discovering-convalescent-therapy-as-an-alternative-to-covid-19-treatment%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fugm.ac.id%5C%2Fen%5C%2Fnews%5C%2F19650-discovering-convalescent-therapy-as-an-alternative-to-covid-19-treatment%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Discovering%20Convalescent%20Therapy%20as%20an%20Alternative%20to%20Covid-19%20Treatment%20%7C%20Universitas%20Gadjah%20Mada%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22Blood%20plasma%20therapy%20or%20convalescent%20treatment%20is%20one%20of%20the%20current%20alternative%20therapies%20in%20treating%20positive%20patients%20with%20Covid-19%20in%20several%20countries.%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fugm.ac.id%5C%2Fen%5C%2Fnews%5C%2F19650-discovering-convalescent-therapy-as-an-alternative-to-covid-19-treatment%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-09-02T03%3A02%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22IJGRJQA9%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Putera%20and%20Hardianti%22%2C%22parsedDate%22%3A%222020-06-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPutera%2C%20D.%20D.%2C%20%26amp%3B%20Hardianti%2C%20M.%20S.%20%282020%29.%20Efficacy%20and%20safety%20of%20convalescent%20plasma%20therapy%20in%20patients%20with%20COVID-19%3A%20arapid%20review%20of%20case%20series.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20Medical%20Sciences%20%28Berkala%20Ilmu%20Kedokteran%29%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B52%26lt%3B%5C%2Fi%26gt%3B%283%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fjurnal.ugm.ac.id%5C%2Fbik%5C%2Farticle%5C%2Fview%5C%2F55821%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fjurnal.ugm.ac.id%5C%2Fbik%5C%2Farticle%5C%2Fview%5C%2F55821%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficacy%20and%20safety%20of%20convalescent%20plasma%20therapy%20in%20patients%20with%20COVID-19%3A%20arapid%20review%20of%20case%20series%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20Dwi%22%2C%22lastName%22%3A%22Putera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mardiah%20Suci%22%2C%22lastName%22%3A%22Hardianti%22%7D%5D%2C%22abstractNote%22%3A%22Coronavirus%20disease%202019%20%28COVID-19%29%20has%20become%20a%20world%20pandemic%20since%20early%202020.Currently%2C%20there%20is%20no%20established%20treatment%20to%20combat%20this%20potentially%20fatal%20disease.%20Convalescent%20plasma%20%28CP%29%20therapy%20has%20a%20strong%20scientific%20basis%20and%20historical%20perspective%20to%20treat%20previous%20viral%20infections%20such%20as%20Ebola%2C%20Middle%20East%20respiratory%20syndrome%20%28MERS%29%20and%20severe%20acute%20respiratory%20syndrome%20%28SARS%29.%20The%20aim%20of%20this%20review%20was%20to%20evaluate%20the%20efficacy%20and%20safety%20of%20convalescent%20plasma%20CP%20therapy%20in%20patients%20with%20COVID-19.We%20searched%20for%20every%20available%20study%20from%20major%20databases%20%28CENTRAL%2C%20MEDLINE%20via%20Ovid%2C%20EMBASE%29%20through%2020th%20April%202020.%20We%20independently%20screened%2C%20extracted%2C%20assessed%20the%20risk%20of%20bias%2C%20analyzed%20the%20data%20using%20SPSS%20version%2026%2C%20and%20narratively%20summarized%20the%20data.%20For%20the%20outcomes%2C%20we%20wanted%20to%20evaluate%20the%20changes%20of%20clinical%20parameters%2C%20radiological%20appearance%2C%20pulmonary%20function%2C%20the%20titer%20of%20neutralizing%20antibody%2C%20viral%20load%2C%20the%20disappearance%20of%20severe%20acute%20respiratory%20syndrome%20coronavirus-2%20%28SARS-CoV-2%29%20RNA%2C%20and%20adverse%20events.We%20found%20five%20case%20series%20from%20our%20literature%20searching.%20The%20overall%20methodological%20quality%20of%20the%20case%20series%20was%20moderate.%20We%20included%2027%20patients%2C%20and%20all%20patients%20received%20CP%20transfusion.%20All%20patients%20experienced%20improvement%20of%20clinical%20symptoms%20and%20pulmonary%20lesions%20after%20receiving%20200%20to%202400%20mL%20%28median%20200%20mL%29%20of%20CP%20transfusion.%20All%20patients%20in%20reported%20studies%20had%20negative%20results%20of%20reverse%20transcriptase-polymerase%20chain%20reaction%28RT-PCR%29%20after%201%20to%2026%20days%20of%20transfusion%20%28median%203%20days%29.%20There%20was%20one%20non-life%20threatening%20adverse%20event%20reported%20after%20CP%20transfusion%20%28facial%20red%20spot%29.%20In%20conclusion%2C%20CP%20therapy%20in%20COVID-19%20patients%20showed%20promising%20results%20as%20it%20improved%20clinical%20symptoms%20and%20parameters%2C%20and%20it%20is%20well-tolerated%20based%20on%20our%20included%20studies.%20However%2C%20further%20expanded%20clinical%20trials%20with%20better%20designs%20are%20still%20required%20to%20evaluate%20the%20efficacy%20of%20this%20treatment%20although%20suchidea%20will%20be%20quite%20challenging%20to%20be%20conducted%20in%20the%20era%20of%20an%20epidemic.%22%2C%22date%22%3A%222020%5C%2F06%5C%2F03%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjurnal.ugm.ac.id%5C%2Fbik%5C%2Farticle%5C%2Fview%5C%2F55821%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222356-3931%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-09-02T02%3A47%3A43Z%22%7D%7D%5D%7D
Libster, R., Pérez Marc, G., Wappner, D., Coviello, S., Bianchi, A., Braem, V., Esteban, I., Caballero, M. T., Wood, C., Berrueta, M., Rondan, A., Lescano, G., Cruz, P., Ritou, Y., Fernández Viña, V., Álvarez Paggi, D., Esperante, S., Ferreti, A., Ofman, G., … Polack, F. P. (2021). Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
New England Journal of Medicine , NEJMoa2033700.
https://doi.org/10.1056/NEJMoa2033700
Joyner, M. J., Bruno, K. A., Klassen, S. A., Kunze, K. L., Johnson, P. W., Lesser, E. R., Wiggins, C. C., Senefeld, J. W., Klompas, A. M., Hodge, D. O., Shepherd, J. R. A., Rea, R. F., Whelan, E. R., Clayburn, A. J., Spiegel, M. R., Baker, S. E., Larson, K. F., Ripoll, J. G., Andersen, K. J., … Wright, R. S. (2020). Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.
Mayo Clinic Proceedings ,
95 (9), 1888–1897.
https://doi.org/10.1016/j.mayocp.2020.06.028
What Is Convalescent Plasma Therapy and How Does It Fight COVID-19? (n.d.). Discover Magazine. Retrieved September 2, 2020, from
https://www.discovermagazine.com/health/what-is-convalescent-plasma-therapy-and-how-does-it-fight-covid-19
Discovering Convalescent Therapy as an Alternative to Covid-19 Treatment | Universitas Gadjah Mada . (n.d.). Retrieved September 2, 2020, from
https://ugm.ac.id/en/news/19650-discovering-convalescent-therapy-as-an-alternative-to-covid-19-treatment
Putera, D. D., & Hardianti, M. S. (2020). Efficacy and safety of convalescent plasma therapy in patients with COVID-19: arapid review of case series.
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) ,
52 (3).
https://jurnal.ugm.ac.id/bik/article/view/55821
0 Comments